Elevance Health Inc.
Elevance Health Reports Q4 2023 Results and Sets Outlook for 2024
Summary
Elevance Health, Inc. reported its financial results for the quarter and full year ended December 31, 2023, revealing an increase in operating revenue by 7% for Q4 and 9.3% for the full year, primarily driven by premium revenue growth and pharmacy product revenue in CarelonRx. The company also announced an increase in the quarterly dividend by 10.1% to $1.63 per share. For 2024, Elevance Health projected GAAP diluted EPS and adjusted diluted EPS to be greater than $34.29 and $37.10 per share, respectively, with flat to low-single-digit growth in total operating revenue.
Profitelligence Alerts
Get alerts for ELV
Be first to know when Elevance Health Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Elevance Health Inc.
Elevance Health Inc., formerly known as Anthem, is a prominent health insurance company in the United States. Its primary function is to provide a wide range of health insurance products and related services to a diverse customer base, including individuals, families, and businesses. Elevance Health focuses on enhancing health and well-being by offering managed care plans tailored to the varying needs of its clients. With a robust portfolio, Elevance Health caters to multiple sectors within the healthcare industry, influencing stakeholders such as healthcare providers, pharmaceutical companies, and medical technology firms. The company plays a critical role in the healthcare market by negotiating coverage terms, managing costs, and ensuring policyholders have access to necessary medical services. As one of the largest health insurers in the nation, Elevance Health holds significant market influence, contributing to shaping healthcare policies and practices through its vast network and strategic partnerships. By leveraging technology and data analytics, the company aims to improve patient outcomes, streamline insurance processes, and foster advancements in personalized healthcare solutions.
Official SEC Documents
Advertisement